Literature DB >> 17218722

Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors.

D Vezzosi1, D Cartier, C Régnier, P Otal, A Bennet, F Parmentier, M Plantavid, A Lacroix, H Lefebvre, P Caron.   

Abstract

ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) is rare and generally presents as a sporadic disease. We describe a familial case of AIMAH with in vivo and in vitro demonstration of aberrant 5-HT4 and vasopressin adrenal receptors. Two sisters presented with clinical and biological features of mild Cushing's syndrome with bilateral macronodular adrenal enlargement on computerized tomography (CT)-scan evaluation. In vivo pharmacological tests showed a significant increase in plasma cortisol after terlipressin and metoclopramide administration. Unilateral adrenalectomy was performed in one of these patients. Reverse transcriptase-PCR analysis of the hyperplastic tissue revealed expression of 5-HT4 receptor isoforms (a), (b), (c), (i), and (n), and of vasopressin receptors, V1 and V2. Their father and brother were overweight, had easy bruisability and presented with biological features of subclinical Cushing's syndrome. CT scan showed moderate adrenal enlargement. In vivo pharmacological screening tests for the detection of adrenal aberrant receptors in the brother were negative. Finally, three out of the two sisters' children were evaluated. They had neither clinical nor biological features of Cushing's syndrome. Their adrenal glands were normal on CT-scan evaluation. In vivo evaluation for the detection of aberrant adrenocortical receptors performed in one of these subjects was negative. In conclusion, this study shows that (i) familial AIMAH could be an autosomal dominantly inherited disorder; (ii) aberrant 5-HT4 serotonin and vasopressin receptors can be expressed in familial AIMAH; and (iii) phenotypic expression of familial AIMAH could be varied in a same family and more pronounced in female than in male patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218722     DOI: 10.1530/eje.1.02324

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH).

Authors:  Maurizio Iacobone; Nora Albiger; Carla Scaroni; Franco Mantero; Ambrogio Fassina; Giovanni Viel; Mauro Frego; Gennaro Favia
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

2.  Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?

Authors:  Holly Emms; Ioanna Tsirou; Treena Cranston; Stylianos Tsagarakis; Ashley B Grossman
Journal:  Endocrine       Date:  2016-06-15       Impact factor: 3.633

3.  ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

Authors:  Stéphanie Espiard; Ludivine Drougat; Rossella Libé; Guillaume Assié; Karine Perlemoine; Laurence Guignat; Gaelle Barrande; Françoise Brucker-Davis; Françoise Doullay; Stephanie Lopez; Emmanuel Sonnet; Florence Torremocha; Denis Pinsard; Nathalie Chabbert-Buffet; Marie-Laure Raffin-Sanson; Lionel Groussin; Françoise Borson-Chazot; Joël Coste; Xavier Bertagna; Constantine A Stratakis; Felix Beuschlein; Bruno Ragazzon; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2015-04-08       Impact factor: 5.958

Review 4.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

Review 5.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

6.  Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor.

Authors:  Hao Wang; Zhenbo Huang; Liansha Huang; Shaona Niu; Xiurong Rao; Jing Xu; Hui Kong; Jianzhong Yang; Chuan Yang; Donghai Wu; Shihua Li; Xiao-Jiang Li; Tonghua Liu; Guoqing Sheng
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

7.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Authors:  Guillaume Assié; Rossella Libé; Stéphanie Espiard; Marthe Rizk-Rabin; Anne Guimier; Windy Luscap; Olivia Barreau; Lucile Lefèvre; Mathilde Sibony; Laurence Guignat; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Franck Letourneur; Bilal Trabulsi; Alix Poussier; Nathalie Chabbert-Buffet; Françoise Borson-Chazot; Lionel Groussin; Xavier Bertagna; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

8.  PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Authors:  Zakariae Bram; Estelle Louiset; Bruno Ragazzon; Sylvie Renouf; Julien Wils; Céline Duparc; Isabelle Boutelet; Marthe Rizk-Rabin; Rossella Libé; Jacques Young; Dennis Carson; Marie-Christine Vantyghem; Eva Szarek; Antoine Martinez; Constantine A Stratakis; Jérôme Bertherat; Hervé Lefebvre
Journal:  JCI Insight       Date:  2016-09-22

Review 9.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

10.  The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.

Authors:  Yunze Xu; Wenbin Rui; Yicheng Qi; Chongyu Zhang; Juping Zhao; Xiaojing Wang; Yuxuan Wu; Qi Zhu; Zhoujun Shen; Guang Ning; Yu Zhu
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.